The estimated Net Worth of Dearborn Partners Llcmadiso... is at least $3.09 Miliardo dollars as of 9 September 2021. Dearborn Llcmadiso owns over 9,200,000 units of Option Care Health stock worth over $1,231,048,346 and over the last 4 years Dearborn sold OPCH stock worth over $1,863,530,000.
Dearborn has made over 9 trades of the Option Care Health stock since 2020, according to the Form 4 filled with the SEC. Most recently Dearborn sold 9,200,000 units of OPCH stock worth $247,480,000 on 9 September 2021.
The largest trade Dearborn's ever made was selling 20,700,000 units of Option Care Health stock on 5 August 2021 worth over $419,175,000. On average, Dearborn trades about 10,855,556 units every 46 days since 2020. As of 9 September 2021 Dearborn still owns at least 37,960,171 units of Option Care Health stock.
You can see the complete history of Dearborn Llcmadiso stock trades at the bottom of the page.
Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten e Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Option Care Health executives and other stock owners filed with the SEC include: